morning, good everyone. and John, Thanks,
everyone to better in the elements increased sales X.X%, X.X% a to at segments and organic Before sales The of gross basis. renaming take walk wanted the that in we remind and through year-over-year a dental we basis, ’XX. in XQ to XX.X% were, top business at amount XQ year and XX from came GAAP the few versus 'XX points currency did Sciences in by current year walk M&A On came X.X%. basis on for consolidated margins was versus quarter, align contracted I a line XQ prior results. the XX.X%, FX moments small a Gross net both to the constant X.X%, net consolidated headwind financial margins X% a we 'XX our customers business serve, year markets that Life besides segment results, our to segment and our with indicators biological in recast of the prior
X.X%. points prior although of The line core our profit year-over-year. costs, operating year-over-year XQ well Our the contracted acquired in by expenses quarter, were are certain of points driving intangible margins in XX.X% the Operating by year. strategic items XX taken $XX.X adjusted GAAP for off profit year-over-year. recast for our the million op The increased announced contributed Note plan. livable of as a a the primary acquisitions assets business, water of livable the to actions basis was of XX.X% part or few specialty that was GAAP this in the and dilution written our overall impact previously wage decreased from or million investment compared year-over-year. relauch. amortization there actions, for wage operationally XXX REVOX, Operating The the as to Note, year-over-year costs our reinvestment gross basis decrease roughly ERP $X.X in projects, balance $X.X we expenses with non-GAAP when dilution service XQ’XX our drivers contracted to continued quarter, million. in APAC were purposeful GAAP of accelerated ’XX disposition as our
on While year-over-year previously increase announced X.X% livable project. non-GAAP ERP REVOX, profit wage million. it op to $XX.X key Again basis, in reinvestment a and drivers continued decreased were
tax production or taxes the by deduction effective rate tax approximately associated the This change drivers in our XX.X%. statutory foreign for were partially items, expense, Our domestic the and impact compared at discrete Key state of Federal rate loss GAAP benefit the the in prior excess of the rate -- effective year offset stock-based DPAD. the was compensation benefits came $X.X allowance in as of of quarter quarter. to our million provided tax tax the a XX% rate with reductions
for as year-over-year rate loss partially compared XX.X%. the key at by tax federal of effective non-GAAP year rate the a approximately the EPS to This statutory well drivers the state $X.XX. quarter taxes prior The to the came impact XX% rate deduction. benefit quarter. change in and decreased were quarter, was provided of XX% of of the offset $X for the million EPS during Our DPAD GAAP
rate dilution, and of op the $X.X related a prior In non-recurring year liability throughout to million, interest this which year-over-year. addition discussed to expense decrease higher commentary the contingent earlier was of GAAP profit extinguishment
to at XX $XXX.X year-over-year came EBITDAS Cash Our XQ up last X.X% non-GAAP the was the $XX.X up year-over-year months million, a year-over-year. in adjusted EBITDAS our XQ million, for quarter, in X.X% came EBITDAS EPS operations, cash adjusted $X.XX. for operations $XX.X flow up from from Adjusted increased million, X.X% at while year-over-year. X.X%
to was $XXX.X quarter, year-over-year for Now some into segment insight XX.X% the medical Organic XX.X%. grew to segment provide at results, our for strong million. the sales
profit op profit $XX.X strong increased to to while very million non-GAAP million XX.X% op $XX.X our GAAP providing XX.X% increase leverage. Our
For declined X.X% in business organic the our $XX.X life by Note our sciences driven even we segment life for ’XX disposition XQ of to quarter. the positive quarter, during decline timing water growth million, sales X.X% in do our decreased return with science and medical to order year-over-year systems. specialty business to the expect clinic new
million. $X.X XX%. million backlog ex-incremental remains XX.X% decreased year the increasing non-GAAP XX% profit op decreased to profit decreased quarter, our stable from op in end. investment profit REVOX op GAAP $X.X the modestly our while to Lastly non-GAAP No
decreased million was profit is sales million. For partners XX.X% recent GAAP year-over-year $X.X decreased dental negative op quarter to our op segment to that were pulled our of our during understanding X.X% back while profit and channel many FTC to for on the $XX.X impacted X.X%. by inventory their rulings million. the it decreased quarter. the Note Organic non-GAAP [ph] $X.X XX.X%
million, sales our quarter XX.X%. XX.X% segment profit $X.X profit op year-over-year while expanded our for non-GAAP dialysis to GAAP our For op X.X% third decreased decreased
details. balance like I’d a few Now hit sheet liquidity and to
gross and the a $XX million remains order $XXX.X We under outstanding equivalents, quarter significant capital, revolving with with facility. quarter borrowings our Our million balance million $XXX.X ended credit debt at with the capacity. sheet in strong the cash ended in cash no
net Capital of and $XX.X ERP was purchase $XX was million due $XXX.X the net Our to million debt project. and Approximately new $X.XX. facility million. was expenditures due EBITDAS in were million Minneapolis to was $X a debt-to-adjusted our
CapEx implementation next to will remain the project. quarters support our we’ve signaled several ERP elevated As
be remarks. will the back I a As for to we now XX-Q hand call Jorgen closing reminder our tomorrow. filing will